Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 4.8B | 5.3B | 4.9B |
Cost of revenue | 3.3B | 3.8B | 3.7B | 3.5B |
Gross profit | 1.3B | 1.0B | 1.6B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 734M | 439M | 776M | 787M |
Other operating expenses | 353M | 311M | 68M | 96M |
Operating income | 192M | -107M | 775M | 595M |
Non operating interest income | ||||
Income | 16M | 43M | 19M | 32M |
Expense | 285M | 227M | 267M | 308M |
Other income expense | 81M | -188M | 86M | 22M |
Pretax income | 17M | -509M | 698M | 456M |
Tax provision | 27M | -225M | -787M | -79M |
Net income | -10M | -284M | 1.5B | 535M |
Basic EPS | 0.0 | -0.7 | 3.8 | 1 |
Diluted EPS | 0.0 | -0.7 | 3.8 | 1 |
Basic average shares | 400M | 391.9M | 392M | 393.3M |
Diluted average shares | 400M | 391.9M | 392M | 393.3M |
EBITDA | 302M | 89M | 1.7T | 1.4B |
Net income from continuing op. | — | -2.4T | 2.4T | 535M |
Minority interests | -6M | -6M | -15M | -16M |
Preferred stock dividends | — | — | — | — |